Associations among cytokines, EGF and lymphocyte subpopulations in patients diagnosed with advanced lung cancer
- 31 May 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Immunology, Immunotherapy
- Vol. 70 (6), 1735-1743
- https://doi.org/10.1007/s00262-020-02823-1
Abstract
Aging is considered the single most significant risk factor for the majority of common malignances including lung cancer. Together immunosenescence, changes occurring with aging in the immune system, and inflammaging, characterizes by a chronic, subclinical accumulation of pro-inflammatory factors, are suggested to stand at the origin of most of the diseases of the elderly, such as cancer. The aim of this study was to determine associations among lymphocyte subpopulations, pro-inflammatory cytokines and epidermal growth factor (EGF) in patients diagnosed with non-small cell lung cancer (NSCLC). Forty-six advanced NSCLC patients were enrolled. Sixteen patients with newly diagnosed and before treatment and 30 patients after first-line platinum-based chemotherapy. Peripheral blood subpopulations were studied by flow cytometry and serum concentrations of soluble factors by ELISA. The frequency of naive CD4(+) T cells, naive B cells and central memory CD8(+) T cells were significantly lower in NSCLC patients after chemotherapy, while effector memory CD4(+) T cells and terminally differentiated CD8(+) T cells were significantly higher. IL-1 beta and TNF alpha significantly correlated among them before and after platinum-based chemotherapy. Terminally differentiated T cells expressing CD57(+) significantly correlated with TNF alpha and IL-1 beta. For the first time, associations between EGF serum levels and terminally differentiated CD4(+) T cells, and memory B cells were detected. This study confirms the association among terminally differentiated lymphocytes and pro-inflammatory cytokines in patients diagnosed with lung cancer, reinforcing the interconnection between terminally differentiated lymphocytes and pro-inflammatory cytokines.This publication has 32 references indexed in Scilit:
- Biomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patientsCancer Immunology, Immunotherapy, 2015
- From “truly naïve” to “exhausted senescent” T cells: When markers predict functionalityCytometry Part A, 2013
- Immunosenescence and gender: a study in healthy CubansImmunity & Ageing, 2013
- Immunology of Aging and Cancer DevelopmentInterdisciplinary topics in gerontology, 2013
- New insights on the role of CD8+CD57+T-cells in cancerOncoImmunology, 2012
- Detection and Characterization of a Novel Subset of CD8+CD57+ T Cells in Metastatic Melanoma with an Incompletely Differentiated PhenotypeClinical Cancer Research, 2012
- Cytotoxic Chemotherapy and CD4+ Effector T Cells: An Emerging Alliance for Durable Antitumor EffectsJournal of Immunology Research, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Effective Inhibition of the Epidermal Growth Factor/Epidermal Growth Factor Receptor Binding by Anti–Epidermal Growth Factor Antibodies Is Related to Better Survival in Advanced Non–Small-Cell Lung Cancer Patients Treated with the Epidermal Growth Factor Cancer VaccineClinical Cancer Research, 2008
- Functional and Vbeta repertoire characterization of human CD8+ T-cell subsets with natural killer cell markers, CD56+ CD57- T cells, CD56+ CD57+ T cells and CD56- CD57+ T cellsImmunology, 2003